Genaera to begin late-stage clinical trials for squalamine

Genaera Corp., Plymouth Meeting, PA, announced late last week that itexpects to begin late-stage clinical trials by early 2005 of its experimentaldrug squalamine to treat age-related macular degeneration (AMD).

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.